MasTec Inc vs Revvity Inc — how do they compare? MasTec Inc trades at $350.55 (market cap $26.60B), while Revvity Inc trades at $110.7 (market cap $11.87B). The key difference: MasTec Inc is far larger — about 2.2× Revvity Inc's market cap, and Revvity Inc pays a 0.26% dividend while MasTec Inc pays none. Which is the better fit depends on your goals.
| MTZ | RVTY | |
|---|---|---|
Market Cap | $26.60B | $11.87B |
Sector | Technology | Technology |
52-Week High | $437.51 | $117.75 |
52-Week Low | $172.51 | $82.26 |
Enterprise Value | $29.34B | $14.36B |
Dividend Yield | — | 0.26% |
Trailing returns across standard periods
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →